Somatropin Injection shortage
Somatropin Injection is currently listed in shortage by the FDA. The FDA lists 1 affected product. This page was last refreshed from FDA data on Sep 22, 2026.
Novo Nordisk is stopping its somatropin injection 30 mg/3 mL, and this change may be permanent. Other somatropin products, including Norditropin (somatropin) in several strengths, are still listed as available from makers that have not reported a shortage.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Somatropin Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Nov 14, 2025Currently in shortage1 of 1 product affected.
-
Nov 14, 2025First reported to the FDA1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Novo Nordisk, Inc. 📞 833-493-4689 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Norditropin, Injection, 30 mg/3 mL (NDC 0169-7703-21) | — | — | Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Somatropin Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Somatropin Injection? options further down this page.
Why is Somatropin Injection in shortage?
Novo Nordisk has let the FDA know that they are permanently stopping the manufacturing of their Norditropin somatropin injection in the 30 mg/3 mL size (the specific package with NDC 0169-7703-21). That's why this particular product is on the shortage list.
It's worth knowing that Novo Nordisk did not share a more detailed public reason for why they made this decision — just that manufacturing of this specific size is being discontinued. This applies only to that one strength and package size from Novo Nordisk, and only reflects what this one manufacturer reported to the FDA.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Somatropin Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Somatropin Injection?
Somatropin injection is currently on the FDA drug-shortage list, and I want to walk you through what that means for you.
The strength affected is the 30 mg/3 mL pen (Norditropin), reported by Novo Nordisk. This strength has no available source right now, and the reason given is that the manufacturer is discontinuing production. Because this is listed as "to be discontinued," this particular product's supply problem may be permanent rather than a short-term gap. That makes a conversation with your prescriber the right next step so you can plan ahead.
Please do not let this alarm you — somatropin is still made in other strengths and by another company, and your care team has good options to keep your treatment steady.
Here is what I suggest, in order:
- Do not stop, skip, or change your dose on your own.
- Since your exact strength is being discontinued, ask your prescriber or pharmacist about options — for example, a different Norditropin strength (such as 5, 10, or 15 mg/1.5 mL) or Omnitrope (5 or 10 mg/1.5 mL), which are the same medicine from Novo Nordisk or Sandoz.
- Your pharmacy may be able to source one of these, though it may not be in local stock.
Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls. This is general, national information and may not match your local pharmacy's actual supply.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Somatropin Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Somatropin Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Norditropin | SOMATROPIN 30 mg/3mL | Injection, Solution · Subcutaneous | Novo Nordisk | 00169-7703-92 |
| Norditropin | SOMATROPIN 5 mg/1.5mL | Injection, Solution · Subcutaneous | Novo Nordisk | 00169-7704-21 |
| Norditropin | SOMATROPIN 10 mg/1.5mL | Injection, Solution · Subcutaneous | Novo Nordisk | 00169-7705-21 |
| Norditropin | SOMATROPIN 15 mg/1.5mL | Injection, Solution · Subcutaneous | Novo Nordisk | 00169-7708-21 |
| Omnitrope | SOMATROPIN 5 mg/1.5mL | Injection, Solution · Subcutaneous | Sandoz Inc | 00781-3001-07 |
| Omnitrope | SOMATROPIN 10 mg/1.5mL | Injection, Solution · Subcutaneous | Sandoz Inc | 00781-3004-07 |
Alternative dosage forms of Somatropin
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 1 productclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Norditropin 30 mg/3mL | Novo | 1 syringe | — | — | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Somatropin Injection — that fall in the same broad treatment class (growth hormones) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other endocrinology/metabolism shortages
Somatropin Injection shortage FAQs
Is Somatropin Injection in shortage?
Which products are affected?
When will Somatropin Injection be available again?
Can I still get Somatropin somewhere?
What should I do if I take Somatropin Injection?
Still have a question about the Somatropin Injection shortage?
Ask a pharmacist about this shortage →View Somatropin Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.